Patents by Inventor Choong Seong HAN

Choong Seong HAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant protein for preventing or treating tissue fibrosis and composition for preventing or treating tissue fibrosis comprising the same
    Patent number: 11028139
    Abstract: The present invention relates to a recombinant protein for preventing or treating tissue fibrosis, which is based on milk fat globule-EGF factor 8 (MFG-E8) protein and comprises the amino acid sequence of SEQ ID NO: 1, and to a composition for preventing or treating tissue fibrosis, which comprises the recombinant protein. The level of the effect of preventing or treating tissue fibrosis by the recombinant protein of the present invention is significantly improved compared to that of conventional milk fat globule-EGF factor 8 (MFG-E8) protein, so that the level of tissue fibrosis can be restored to a level very close to that in normal tissue by the prevention and treatment of tissue fibrosis.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: June 8, 2021
    Assignee: NEXEL CO., LTD.
    Inventors: Choong Seong Han, Dong Hun Woo, Gun Sik Cho, Jeong Seong Kim, Geun Ho An, Hye Ryeon Jeon
  • RECOMBINANT PROTEIN FOR PREVENTING OR TREATING TISSUE FIBROSIS AND COMPOSITION FOR PREVENTING OR TREATING TISSUE FIBROSIS COMPRISING THE SAME
    Publication number: 20180334486
    Abstract: The present invention relates to a recombinant protein for preventing or treating tissue fibrosis, which is based on milk fat globule-EGF factor 8 (MFG-E8) protein and comprises the amino acid sequence of SEQ ID NO: 1, and to a composition for preventing or treating tissue fibrosis, which comprises the recombinant protein. The level of the effect of preventing or treating tissue fibrosis by the recombinant protein of the present invention is significantly improved compared to that of conventional milk fat globule-EGF factor 8 (MFG-E8) protein, so that the level of tissue fibrosis can be restored to a level very close to that in normal tissue by the prevention and treatment of tissue fibrosis.
    Type: Application
    Filed: May 31, 2018
    Publication date: November 22, 2018
    Applicant: NEXEL CO., LTD.
    Inventors: Choong Seong HAN, Dong Hun WOO, Gun Sik CHO, Jeong Seong KIM, Geun Ho AN, Hye Ryeon JEON